1. Home
  2. AVBH vs IMRX Comparison

AVBH vs IMRX Comparison

Compare AVBH & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVBH
  • IMRX
  • Stock Information
  • Founded
  • AVBH 2003
  • IMRX 2008
  • Country
  • AVBH United States
  • IMRX United States
  • Employees
  • AVBH N/A
  • IMRX N/A
  • Industry
  • AVBH
  • IMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AVBH
  • IMRX Health Care
  • Exchange
  • AVBH Nasdaq
  • IMRX Nasdaq
  • Market Cap
  • AVBH 282.1M
  • IMRX 232.9M
  • IPO Year
  • AVBH N/A
  • IMRX 2021
  • Fundamental
  • Price
  • AVBH $25.99
  • IMRX $6.19
  • Analyst Decision
  • AVBH Strong Buy
  • IMRX Strong Buy
  • Analyst Count
  • AVBH 4
  • IMRX 4
  • Target Price
  • AVBH $28.38
  • IMRX $17.75
  • AVG Volume (30 Days)
  • AVBH 28.2K
  • IMRX 1.9M
  • Earning Date
  • AVBH 10-23-2025
  • IMRX 11-12-2025
  • Dividend Yield
  • AVBH N/A
  • IMRX N/A
  • EPS Growth
  • AVBH N/A
  • IMRX N/A
  • EPS
  • AVBH N/A
  • IMRX N/A
  • Revenue
  • AVBH $22,129,000.00
  • IMRX N/A
  • Revenue This Year
  • AVBH $21.53
  • IMRX N/A
  • Revenue Next Year
  • AVBH $17.90
  • IMRX N/A
  • P/E Ratio
  • AVBH N/A
  • IMRX N/A
  • Revenue Growth
  • AVBH N/A
  • IMRX N/A
  • 52 Week Low
  • AVBH $19.75
  • IMRX $1.10
  • 52 Week High
  • AVBH $26.59
  • IMRX $10.08
  • Technical
  • Relative Strength Index (RSI)
  • AVBH N/A
  • IMRX 51.11
  • Support Level
  • AVBH N/A
  • IMRX $5.23
  • Resistance Level
  • AVBH N/A
  • IMRX $6.44
  • Average True Range (ATR)
  • AVBH 0.00
  • IMRX 0.44
  • MACD
  • AVBH 0.00
  • IMRX -0.00
  • Stochastic Oscillator
  • AVBH 0.00
  • IMRX 71.58

About AVBH Avidbank Holdings Inc. Common stock

Avidbank Holdings Inc is a full-service commercial bank. It offers various services such as commercial and industrial lending, venture lending, structured finance, asset-based lending, sponsor finance, real estate construction, and commercial real estate lending.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: